Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORAL Surveillance: Tofacitinib Safety vs TNF Inhibitors in RA
NCT02092467Phase 4Completed
- Sponsor
- Pfizer
- Start
- Mar 2014
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 30
01
Overview
A Phase 4 trial of tofacitinib oral solution in rheumatoid arthritis (RA), sponsored by Pfizer. Started Mar 2014; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02092467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02092467.